PLASMA CYTOKINE LEVELS IN HEMOLYTIC-UREMIC SYNDROME

被引:62
作者
VANDEKAR, NCAJ
SAUERWEIN, RW
DEMACKER, PNM
GRAU, GE
VANHINSBERGH, VWM
MONNENS, LAH
机构
[1] UNIV NIJMEGEN HOSP,DEPT INTERNAL MED,6500 HB NIJMEGEN,NETHERLANDS
[2] UNIV NIJMEGEN HOSP,DEPT MED MICROBIOL,6500 HB NIJMEGEN,NETHERLANDS
[3] CTR MED UNIV GENEVA,GENEVA,SWITZERLAND
[4] TNO PG,GAUBIUS LAB,LEIDEN,NETHERLANDS
来源
NEPHRON | 1995年 / 71卷 / 03期
关键词
HEMOLYTIC UREMIC SYNDROME; CYTOKINES; INTERLEUKIN-B; ACUTE RENAL FAILURE; SOLUBLE TUMOR NECROSIS FACTOR; RECEPTORS; TUMOR NECROSIS FACTOR-A; INTERLEUKIN-1;
D O I
10.1159/000188737
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The cytokines tumor necrosis factor-alpha (TNF-alpha) and its soluble TNF receptors 55 and 75 (sTNFR55, sTNFR75), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) were measured in plasma from 13 patients with the hemolytic uremic syndrome (HUS) on admission. No significant changes in the plasma levels of TNF-alpha and IL-1 beta were detected in the HUS patients as compared to the plasma levels of the control groups. Levels of IL-6 were significantly elevated in the plasma of those HUS patients who had extrarenal manifestations, consisting of seizures, loss of consciousness, coma and pancreatic necrosis. Although the exact function of IL-6 in the plasma of HUS patients is still unknown and the group of HUS patients is small, plasma IL-6 is associated with the severity and outcome of the disease. Plasma levels of sTNR55 and sTNFR75 were significantly elevated in all HUS patients compared to the healthy controls, but they were also elevated in the children with chronic renal failure. This indicates that elevated levels of circulating sTNFR should be carefully interpreted when kidney failure exists.
引用
收藏
页码:309 / 313
页数:5
相关论文
共 26 条
[1]   CIRCULATING SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS, INTERLEUKIN-2 RECEPTORS, TUMOR-NECROSIS-FACTOR-ALPHA, AND INTERLEUKIN-6 LEVELS IN RHEUMATOID-ARTHRITIS - LONGITUDINAL EVALUATION DURING METHOTREXATE AND AZATHIOPRINE THERAPY [J].
BARRERA, P ;
BOERBOOMS, AMT ;
JANSSEN, EM ;
SAUERWEIN, RW ;
GALLATI, H ;
MULDER, J ;
DEBOO, T ;
DEMACKER, PNM ;
VANDEPUTTE, LBA ;
VANDERMEER, JWM .
ARTHRITIS AND RHEUMATISM, 1993, 36 (08) :1070-1079
[2]  
BEMELMANS MHA, 1993, J IMMUNOL, V150, P2007
[3]   INTERLEUKIN-6 PRODUCTION BY HUMAN PROXIMAL TUBULAR EPITHELIAL-CELLS IN-VITRO - ANALYSIS OF THE EFFECTS OF INTERLEUKIN-1-ALPHA (IL-1-ALPHA) AND OTHER CYTOKINES [J].
BOSWELL, RN ;
YARD, BA ;
SCHRAMA, E ;
VANES, LA ;
DAHA, MR ;
VANDERWOUDE, FJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (06) :599-606
[4]   PROGNOSTIC VALUES OF TUMOR-NECROSIS-FACTOR CACHECTIN, INTERLEUKIN-1, INTERFERON-ALPHA, AND INTERFERON-GAMMA IN THE SERUM OF PATIENTS WITH SEPTIC SHOCK [J].
CALANDRA, T ;
BAUMGARTNER, JD ;
GRAU, GE ;
WU, MM ;
LAMBERT, PH ;
SCHELLEKENS, J ;
VERHOEF, J ;
GLAUSER, MP .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (05) :982-987
[5]   SEROLOGICAL DETECTION OF VEROCYTOTOXIN-PRODUCING ESCHERICHIA-COLI IN PATIENTS WITH HEMOLYTIC-UREMIC SYNDROME IN WESTERN-EUROPE [J].
CHART, H ;
VANDERKAR, NCA ;
TOLBOOM, JJM ;
MONNENS, LMH ;
ROWE, B .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (09) :707-709
[6]  
FITZPATRICK MM, 1993, KIDNEY INT, V42, P951
[7]  
FONG JSC, 1982, PEDIATR CLIN N AM, V29, P835
[8]   TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 IN THE SERUM OF CHILDREN WITH SEVERE INFECTIOUS PURPURA [J].
GIRARDIN, E ;
GRAU, GE ;
DAYER, JM ;
ROUXLOMBARD, P ;
LAMBERT, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (07) :397-400
[9]   A REPORTER TRANSGENE INDICATES RENAL-SPECIFIC INDUCTION OF TUMOR-NECROSIS-FACTOR (TNF) BY SHIGA-LIKE TOXIN - POSSIBLE INVOLVEMENT OF TNF IN HEMOLYTIC-UREMIC SYNDROME [J].
HAREL, Y ;
SILVA, M ;
GIROIR, B ;
WEINBERG, A ;
CLEARY, TB ;
BEUTLER, B .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (05) :2110-2116
[10]   RECENT ADVANCES IN UNDERSTANDING THE PATHOGENESIS OF THE HEMOLYTIC UREMIC SYNDROMES [J].
KAPLAN, BS ;
CLEARY, TG ;
OBRIG, TG .
PEDIATRIC NEPHROLOGY, 1990, 4 (03) :276-283